[Tumors of the lymphatic system. Part II: therapy].
D000380:Agranulocytosis / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy; D011379:Prognosis; D011879:Radiotherapy Dosage; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents
Tumorerkrankungen des lymphatischen Systems. II. Teil: Therapie.